Latest News and Press Releases

TORONTO, Dec. 15, 2009 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTCBB:POLXF) reports financial results for its third fiscal quarter, the three-month period ended October 31, 2009. ...

TORONTO, Sept. 14, 2009 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTCBB:POLXF) (the "Company") reports financial results for the second quarter of fiscal 2010, the three-month period ending...

TORONTO, June 15, 2009 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTCBB:POLXF) (the "Company") reports financial results for the first quarter of fiscal 2010, the three-month period ending...

TORONTO, April 30, 2009 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTCBB:POLXF) (the "Company") reports financial results for its fiscal year ended January 31, 2009. All figures are reported...

TORONTO, Dec. 12, 2008 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTCBB:POLXF) reports financial results for its third fiscal quarter, the three-month period ended October 31, 2008. ...

TORONTO, Sept. 12, 2008 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited reports on financial results of operations for the second quarter of fiscal 2009, ending July 31, 2008, as follows: ...

TORONTO, Sept. 11, 2008 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF). The Company has been advised that the Nasdaq Hearings Panel has decided to delist the Company's securities...

TORONTO, Aug. 4, 2008 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) reports that the final analysis from the Phase III clinical trial of Ushercell, a cellulose sulphate gel...

TORONTO, July 15, 2008 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (the "Company"), (Nasdaq:POLXF) announced today that on July 14, 2008, it received a Nasdaq Staff Determination Letter from...

TORONTO, June 24, 2008 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) has issued a Business Outlook report, outlining summaries of the Company's business, financials, operations...